Literature DB >> 5822653

Contrast agent design. Some aspects on the synthesis of water soluble contrast agents of low osmolality.

T Almén.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5822653     DOI: 10.1016/s0022-5193(69)80047-0

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


× No keyword cloud information.
  16 in total

1.  Ventriculography with Amipaque.

Authors:  S Cronqvist
Journal:  Neuroradiology       Date:  1976-10-27       Impact factor: 2.804

Review 2.  The adverse effects of angiographic radiocontrast media.

Authors:  M Westhoff-Bleck; J S Bleck; S Jost
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

Review 3.  One century of diagnostic imaging in medicine.

Authors:  M Elke
Journal:  Experientia       Date:  1995-07-14

4.  Experimental evaluation of watersoluble contrast media for myelography.

Authors:  J Praestholm
Journal:  Neuroradiology       Date:  1977-03-28       Impact factor: 2.804

5.  Low osmolar contrast media.

Authors:  R G Grainger
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-21

6.  Elimination kinetics of iopamidol, a new water soluble nonionic radiographic contrast medium, analyzed by radioactivation.

Authors:  O Muratore; S Saitta; G Mallarini; P Corvisiero; M Sanzone
Journal:  Experientia       Date:  1983-01-15

7.  Adverse side effects of metrizamide in myelography.

Authors:  H J Gelmers
Journal:  Neuroradiology       Date:  1979-09-26       Impact factor: 2.804

Review 8.  The clinical application of radiopharmaceuticals.

Authors:  N E Leeds
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

9.  Myelography with iopamidol, a nonionic water-soluble contrast medium: incidence of complications.

Authors:  P Bassi; A Cecchini; P Dettori; E Signorini
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

10.  Preclinical safety assessment of contrast media: predictive value.

Authors:  J O Karlsson
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.